Cancer

GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

MENLO PARK, Calif., Aug. 21, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect…

1 year ago

Ultrasound Market to be Worth $18.07 billion by 2031 – Exclusive Report by Meticulous Research®

REDDING, Calif., Aug. 21, 2024 /PRNewswire/ -- According to a new market research report, 'Ultrasound Market Size, Share, Forecast, & Trends Analysis…

1 year ago

Dovetail Genomics and Goenomics GmbH Announce Strategic Partnership to Enhance Genome Annotation Services

Partnership to Provide Faster, Richer Annotation Services for Evolutionary Biology, Conservation, and Agriculture SCOTTS VALLEY, Calif. and GÖTTINGEN, Germany, Aug.…

1 year ago

Limmi adds nationally recognized expert in early disease detection and microbiome biology to Advisory Board

CARLSBAD, Calif., Aug. 21, 2024 /PRNewswire/ -- Today, Limmi – an AI startup dedicated to transforming patient outcomes by rapidly discovering…

1 year ago

Theralase(R) Demonstrates Unique Ability to Activate Rutherrin(R) With Diabetes Drug

TORONTO, ON / ACCESSWIRE / August 21, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage…

1 year ago

Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress

Presentation to discuss latest developments in future AI applications in interventional radiology, specifically highlighting the early results from the Company’s…

1 year ago

Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium

HealthCCSng V2.0 introduces additional ‘zero calcium’ categorization of coronary artery calcium (CAC) and generates a numerical calcium score with corresponding…

1 year ago

Monopar Receives Clearance to Proceed with Phase 1 Therapeutic Trial of Novel Radiopharmaceutical in Advanced Cancers

WILMETTE, Ill., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing…

1 year ago

Tempest Announces the Appointment of Troy M. Wagner as Vice President of Quality Assurance

Expansion of leadership team to strengthen global clinical expertiseBRISBANE, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq:…

1 year ago

Olema Oncology to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference

SAN FRANCISCO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company…

1 year ago